 |
PDBsum entry 6pme
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Synthetic inhibitor leads of human tropomyosin receptor kinase a (htrka).
|
 |
|
Authors
|
 |
G.Subramanian,
R.Vairagoundar,
S.J.Bowen,
N.Roush,
T.Zachary,
C.Javens,
T.Williams,
A.Janssen,
A.Gonzales.
|
 |
|
Ref.
|
 |
RSC Med Chem, 2020,
11,
370-377.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
In silico virtual screening followed by in vitro biochemical,
biophysical, and cellular screening resulted in the identification of distinctly
different hTrkA kinase domain inhibitor scaffolds. X-ray structural
analysis of representative inhibitors bound to hTrkA kinase domain
defined the binding mode and rationalized the mechanism of action. Preliminary
assessment of the sub-type selectivity against the closest hTrkB isoform,
and early ADME guided the progression of select inhibitor leads in the screening
cascade. The possibility of the actives sustaining to known hTrkA
resistance mutations assessed in silico offers initial guidance into the
required multiparametric lead optimization to arrive at a clinical candidate.
|
 |
|
|
|
|
 |